Summary: IMS R&D Focus
The information contained in this Lesson gives you a complete picture of File 445/955—IMS R&D Focus. This database provides you with a comprehensive and informative look at a drug as it moves through the drug pipeline.
File 445/955 is especially strong in that it provides:
- Both a snapshot of the drug in the Profile sub-file and related news in the News sub-file.
- Excellent company name accessibility, with consistent indexing of originators, licensees, their respective parent companies, and geographic locations.
- Good source for checking licensing availability providing contact information for follow-up.
- Development status including both current world status and an event by event developmental history worldwide
- Text which includes an abstract that discusses various aspects of the drug, with references clearly defined.
- Concise summaries of basic patent information
- Extensive geographic scope
- Emphasis on commercial impact
The chart below identifies important parts of the record for File 445/955. We will continue to add to this chart as we review the other databases in the drug pipeline in subsequent lessons.
| Database Features | IMS R&D Focus* (File 445/955) |
|---|---|
| Drug Name | X |
| Trade Name | X |
| Originator | X |
| Licensee/Licensor | X |
| Patent Assignee | X |
| CAS® Registry Number | X |
| Laboratory Code | X |
| Pharmacological Action | X |
| Pharmacokinetics | |
| Therapeutic Class Code | X |
| Target data | |
| Clinical Indications | X |
| Nomenclature | X |
| Molecular formula | |
| Molecular code | X |
| New Entity | |
| Current Development Status | X |
| Development History | X |
| Abstract | X |
| Text | X1 |
| Chemical Structure Images | X |
| Chemical Name | X |
| Synthesis | |
| Substance Origin/Origin of Materials | X |
| References |
* Database includes Profile record and news record.
1 Text includes Commercial, Scientific, Patent summaries.
If you have reviewed the chart for File 445/955, and understand the content of this database, go to Lesson 3 in which we will discuss Dialog File 128/928—Pharmaprojects.
